|
Market Closed -
Borsa Italiana
19:45:00 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.085 EUR | -0.46% |
|
-2.25% | -26.19% |
| 08-31 | Milan in the pink at the open, oil stocks lead the MIB | AN |
| 08-31 | Futures weak; Brent higher after US-Iran attacks | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.46% | -2.25% | -22.22% | -11.79% | 10.8M | ||
| -0.65% | -2.93% | +47.52% | +87.34% | 1,001B | ||
| -0.29% | -3.51% | +48.78% | +63.27% | 642B | ||
| +0.83% | +0.26% | +16.76% | +72.52% | 451B | ||
| -0.38% | -3.59% | +28.24% | +35.57% | 340B | ||
| -0.09% | -13.54% | +10.08% | +26.87% | 263B | ||
| -0.43% | -2.48% | -2.07% | +11.48% | 247B | ||
| -1.34% | -13.70% | +33.47% | +44.18% | 207B | ||
| -3.44% | -7.51% | -20.08% | -59.58% | 197B | ||
| -0.75% | -4.82% | +21.94% | +86.55% | 180B | ||
| Average | -0.70% | -5.17% | +16.24% | +35.64% | 352.63B | |
| Weighted average by Cap. | -0.52% | -4.33% | +29.80% | +55.48% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















